Back to
FEDERATED HERMES, INC.
RARE29 quarters
Position history for
FEDERATED HERMES, INC.'s holdings in ULTRAGENYX PHARMACEUTICAL IN
No. Federated Hermes exited its RARE (Ultragenyx Pharmaceutical in) position in Q4 2025. Its Q3 2025 13F listed 496,060 shares worth $14.9M. Federated Hermes already held RARE in its Q4 2018 13F, the earliest on record, and held it in 28 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$55.5M
Total Shares Change
-1.3M
Quarter-by-Quarter History
Other major holders of RARE: PRICE T ROWE ASSOCIATES INC /MD/, Capital Research Global Investors